pubrio
Peptron logo
其他領域Founded 1997🇰🇷 南韓

SmartDepotTM is Peptron’s proprietary ultrasonic spray drying technology for the preparation of sustained release (SR) injectable microsphere formulation of drug. Recently, this long-acting technology has attracted the intense attention of global pharmaceutical companies since the costs for developing new medicines are soaring and patent expirations of many blockbuster drugs are just around the corner. SmartDepotTM is a next generation technology featuring various release profiles from 1 week to 6 months, showing high production yield and enabling mass production, differentiated from existing SR technology. SmartDepotTM is highly applicable to various peptide and small molecule drug. Patented technology ensures manufacturing and quality aspects of the competitive product development. Peptron has been developing anti-diabetes drug, anti-neurodegenerative disease drug, anti-acromegaly drug, anti-schizophrenia drug, which will be marketed in collaboration with global partners.

成立年份
1997
行業
其他領域
股票
koe: 087010.KQ
總部
🇰🇷37-24, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon, Korea, Republic Of, 34054
專長
其他領域

擴張情報

全新 · Pubrio 獨家

我們正在追蹤 Peptron 的市場擴張

全球擴張

即時
階段
探索中投入中進入中營運中

活動脈搏

過去 90 日內有 1 個訊號。

過去 90 日
招聘
0
無活動
市場推廣與公關
0
無活動
產品與技術
0
無活動
+2個類別已鎖定
已顯示 5 個中的 3 個
值得了解

關於 Peptron 的常見問題

關於 Peptron 業務、市場及增長訊號的快速解答。

SmartDepotTM is Peptron’s proprietary ultrasonic spray drying technology for the preparation of sustained release (SR) injectable microsphere formulation of drug. Recently, this long-acting technology has attracted the intense attention of global pharmaceutical companies since the costs for developing new medicines are soaring and patent expirations of many blockbuster drugs are just around the corner. SmartDepotTM is a next generation technology featuring various release profiles from 1 week to 6 months, showing high production yield and enabling mass production, differentiated from existing SR technology. SmartDepotTM is highly applicable to various peptide and small molecule drug. Patented technology ensures manufacturing and quality aspects of the competitive product development. Peptron has been developing anti-diabetes drug, anti-neurodegenerative disease drug, anti-acromegaly drug, anti-schizophrenia drug, which will be marketed in collaboration with global partners.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。